The protein is synthesized in Escherichia coli expression systems and purified via immobilized metal affinity chromatography (IMAC) leveraging its His-tag. Critical production parameters include:
Uncharacterized Role: YhcE’s biological function in B. subtilis remains unknown, though its gene neighbors (e.g., yhcS, encoding a sortase) suggest potential involvement in cell wall anchoring or stress response .
Contrast with YhcR: Unlike YhcE, the B. subtilis surface protein YhcR has been studied extensively. YhcR is anchored via the YhcS sortase, enabling its use in surface-display biotechnology applications .
Recombinant YhcE serves as a foundational tool for:
Functional Proteomics: CRISPR knockouts or pull-down assays to identify interactors.
Structural Resolution: Cryo-EM or X-ray crystallography to elucidate membrane topology.
Biotechnological Engineering: Potential fusion with reporter enzymes, pending discovery of its native sorting signals.
KEGG: bsu:BSU09050
STRING: 224308.Bsubs1_010100005008
YhcE is an uncharacterized protein in Bacillus subtilis that appears to be part of an ABC transporter operon. Current structural analysis indicates that YhcE contains six putative membrane-spanning domains (MSDs), suggesting it functions as a membrane component within this transport system. While the specific function of YhcE remains unclear, it exists in an operon alongside other proteins such as YhcH and YhcI, which are believed to form components of an ABC transporter system .
YhcE's genomic context places it in the prkA-addAB region of the B. subtilis chromosome. This region contains several ABC-like transporters, with YhcE specifically being part of a transporter system where YhcI (homologous to BcrB from Bacillus licheniformis) likely constitutes the membrane component, and YhcH potentially functions as the substrate-binding domain .
The yhcE gene is located within an operon structure in the prkA-addAB region of the B. subtilis chromosome. It is organized alongside other genes that encode components of an ABC transporter system. Specifically, the operon includes yhcH (likely encoding a substrate-binding domain) and yhcI (encoding a membrane component with six membrane-spanning domains homologous to BcrB from B. licheniformis) .
This genomic organization provides important contextual information suggesting that YhcE functions as part of a transport system. The gene arrangement within this region includes multiple ABC transporter components, reflecting the common functional clustering of related genes in bacterial operons .
YhcE is primarily characterized by its six putative membrane-spanning domains (MSDs), which strongly suggest its role as a membrane component of an ABC transporter system. This structural feature is typical of proteins involved in substrate translocation across membranes .
Unlike some other components in the same operon, YhcE does not appear to contain ATP-binding domains or substrate-binding domains, which further supports its likely role specifically as the membrane component of the transporter. The presence of six MSDs is consistent with other transmembrane proteins involved in substrate translocation in B. subtilis and related organisms .
For optimal expression of recombinant YhcE in B. subtilis, researchers should consider the following methodological approach:
Expression system selection: For membrane proteins like YhcE with six membrane-spanning domains, using B. subtilis itself as an expression host often yields better results than heterologous systems, as it provides the native membrane environment and post-translational machinery.
Promoter selection: Inducible promoters such as the xylose-inducible system (similar to that used for comK expression in B. subtilis) can provide controlled expression . For membrane proteins like YhcE, moderate expression levels are often preferable to prevent membrane stress and protein aggregation.
Growth conditions: Based on protocols used for other B. subtilis proteins, growth at 30°C rather than 37°C following induction can improve proper folding of membrane proteins .
Induction timing: Inducing expression during mid-log phase (OD600 of approximately 0.6-0.8) typically provides a balance between cell density and protein production capacity.
Media composition: Rich media such as LB can be used, but for membrane proteins, supplementation with additional phospholipids may improve integration into membranes .
Purifying membrane proteins like YhcE requires specialized approaches:
Membrane fraction isolation: Following cell lysis, differential centrifugation should be employed to isolate membrane fractions. Typically, low-speed centrifugation (5,000-10,000 × g) removes cell debris, followed by high-speed ultracentrifugation (100,000 × g) to pellet membrane fractions.
Detergent solubilization: For a protein with six MSDs like YhcE, mild non-ionic detergents such as n-dodecyl-β-D-maltoside (DDM) or digitonin are recommended for initial solubilization screens, as they maintain protein-protein interactions and functional integrity.
Affinity tags: Incorporating a His6-tag (similar to the approach used for the Phy protein in E. coli SD58 ) can facilitate purification using immobilized metal affinity chromatography (IMAC).
Buffer optimization: Purification buffers should maintain protein stability while preventing aggregation, typically containing:
20-50 mM Tris-HCl or phosphate buffer (pH 7.5-8.0)
100-300 mM NaCl
5-10% glycerol
Critical micelle concentration (CMC) of the selected detergent
Protease inhibitors
Size-exclusion chromatography: As a final polishing step to separate properly folded protein from aggregates and to assess oligomeric state in detergent micelles.
Determining substrate specificity of an ABC transporter containing YhcE requires a systematic approach:
Genetic knockout studies: Create yhcE deletion mutants in B. subtilis (similar to the approach used for yhcR ) and assess phenotypic changes under various growth conditions. This may reveal sensitivity to specific compounds, suggesting potential substrates.
Transport assays with reconstituted systems:
Purify all components of the ABC transporter (YhcE, YhcH, YhcI)
Reconstitute the complex in liposomes
Test transport of radioactively or fluorescently labeled potential substrates
Monitor substrate accumulation inside liposomes or substrate depletion from the external medium
ATPase activity coupling assays: Since ABC transporters couple ATP hydrolysis to substrate transport, measuring ATPase activity in the presence of different potential substrates can indicate substrate recognition.
Substrate binding assays with the binding protein component: If YhcH functions as predicted as the substrate-binding domain, perform direct binding assays using:
Isothermal titration calorimetry (ITC)
Surface plasmon resonance (SPR)
Fluorescence-based binding assays
Comparative genomics: Analyze conserved genomic context and co-occurrence patterns of yhcE with other genes across different bacterial species, which may provide insights into its functional associations .
Several methodological approaches can be employed to characterize YhcE interactions:
In vivo protein-protein interaction studies:
Bacterial two-hybrid system
Split-GFP complementation assays
Förster resonance energy transfer (FRET) with fluorescently tagged proteins
Co-immunoprecipitation using specific antibodies or epitope tags
In vitro interaction analysis:
Co-purification of interacting partners
Blue native PAGE to identify stable complexes
Pulldown assays using purified components
Crosslinking studies followed by mass spectrometry
Structural studies to visualize the transport complex:
Cryo-electron microscopy of the reconstituted complex
X-ray crystallography (challenging for membrane proteins but possible with appropriate stabilization)
Hydrogen-deuterium exchange mass spectrometry to map interaction interfaces
Functional complementation assays:
Transcriptomic analysis provides valuable insights into yhcE regulation:
RNA-seq approach:
Isolate RNA from B. subtilis cultures grown under various conditions (different growth phases, stress conditions, nutrient limitations)
Perform RNA-seq to quantify yhcE expression levels
Identify conditions that upregulate or downregulate yhcE expression
Compare expression patterns with other genes in the ABC transporter operon
Promoter analysis and transcription start site mapping:
Identification of regulatory factors:
Perform chromatin immunoprecipitation sequencing (ChIP-seq) with known transcription factors
Create transcription factor knockout strains and assess yhcE expression
Use electrophoretic mobility shift assays (EMSAs) to identify proteins that bind to the yhcE promoter region
Operon structure confirmation:
To comprehensively study the impact of yhcE deletion:
Construction of genetic knockouts:
Create a clean yhcE deletion mutant using allelic replacement techniques
Generate complementation strains expressing yhcE from an inducible promoter to confirm phenotypic changes are directly attributable to yhcE loss
Create double or triple mutants lacking multiple components of the ABC transporter system
Phenotypic characterization:
Growth curve analysis under various conditions (different media, temperatures, pH values, osmotic conditions)
Stress tolerance assays (antibiotic susceptibility, metal ion sensitivity, oxidative stress)
Membrane integrity analysis using membrane-permeable dyes
Metabolomic profiling to identify accumulated or depleted metabolites
Transport assays:
Measure uptake or export of radiolabeled substrates
Monitor intracellular accumulation of fluorescent compounds
Assess changes in membrane potential using voltage-sensitive dyes
Global impact analysis:
CRISPR-Cas9 technologies offer powerful approaches for studying YhcE:
Precise genome editing:
Generate clean deletions, point mutations, or domain deletions in yhcE
Introduce specific amino acid substitutions in the membrane-spanning domains to assess their importance
Create translational fusions with reporter tags at the genomic locus
CRISPRi-based repression:
Use catalytically inactive Cas9 (dCas9) to repress yhcE expression without permanently altering the genome
Implement tunable repression systems to achieve different levels of knockdown
Create multiplexed CRISPRi systems targeting multiple components of the ABC transporter simultaneously
CRISPR activation (CRISPRa):
Use modified dCas9 fused to transcriptional activators to upregulate yhcE expression
Study the effects of overexpression on cellular physiology and transport activity
CRISPR-based screening:
Perform genome-wide CRISPR screens to identify genetic interactions with yhcE
Identify synthetic lethal or synthetic rescue interactions that provide insights into function
Base editing and prime editing:
Use CRISPR-based precision editing to introduce specific mutations without double-strand breaks
Systematically mutate conserved residues in membrane-spanning domains to assess functional importance
Advanced computational methods provide valuable insights into YhcE:
Homology modeling and threading approaches:
Use proteins with known structures as templates for modeling YhcE structure
Specifically focus on other ABC transporter membrane components with resolved structures
Validate models through molecular dynamics simulations in membrane environments
Deep learning approaches:
Apply AlphaFold2 or RoseTTAFold to predict YhcE structure from sequence
Use these models to identify potential substrate binding sites or protein-protein interaction interfaces
Molecular dynamics simulations:
Perform simulations of YhcE in lipid bilayers to study conformational dynamics
Investigate potential substrate pathways through the membrane domains
Study the effects of mutations on protein stability and function
Functional prediction using genomic context:
Analyze gene neighborhood conservation across bacterial species
Identify co-evolution patterns with potential interaction partners
Use guilt-by-association approaches based on genomic context across diverse bacterial species
Substrate prediction:
A comparative analysis of YhcE with other ABC transporter membrane components reveals:
Structural comparison:
YhcE contains six membrane-spanning domains (MSDs), similar to YhcI and YheI/YheH, which are other membrane components of ABC transporters in B. subtilis
Unlike YheI and YheH, which contain both MSDs and ATP-binding domains, YhcE appears to function solely as a membrane component without ATP-binding capability
The transmembrane topology of YhcE is similar to other ABC transporter membrane components, but detailed comparative analysis would require experimental verification
Functional comparison:
YhcE is part of an ABC transporter with unclear function, whereas other B. subtilis ABC transporters have more defined roles:
The YheJ-YheH system may be involved in phospholipid transport based on homology to phospholipid methyltransferase
The YhaQ-YhaP system is homologous to Na+ ABC transporter proteins NatA and NatB
The YhaD-YhaC-YhaB (EcsA-EcsB-EcsC) system is involved in exoprotein production, sporulation, and competence
Evolutionary relationships:
Comparative genomics provides evolutionary insights:
Conservation analysis:
Examine the presence/absence of yhcE homologs across different Bacillus species and related genera
Assess sequence conservation patterns, particularly in the membrane-spanning domains
Identify species-specific variations that might indicate functional adaptations
Synteny analysis:
Compare the genomic context of yhcE across Bacillus species to identify conserved operonic structures
Evaluate whether yhcE consistently appears with the same partner genes (yhcH, yhcI) across species
Identify instances where gene order is disrupted, potentially indicating functional divergence
Selection pressure analysis:
Calculate dN/dS ratios across yhcE sequences to identify regions under purifying or positive selection
Identify functionally important residues based on evolutionary conservation patterns
Detect potential coevolution patterns with interacting partners
Horizontal gene transfer assessment:
Analyze GC content and codon usage bias to detect potential horizontal gene transfer events
Construct phylogenetic trees to identify incongruence with species phylogeny
This approach is particularly relevant given B. subtilis' natural competence and ability to acquire foreign DNA, as demonstrated in experimental evolution studies
YhcE can potentially be utilized in protein display systems:
Fusion protein design strategies:
Create chimeric proteins fusing YhcE (or portions containing membrane-spanning domains) with recombinant proteins of interest
Design optimal linker sequences to ensure proper folding and accessibility of the displayed protein
Consider domain orientation and topology to maximize surface exposure
Expression optimization:
Develop expression systems with controlled induction similar to those used for other surface display proteins
Balance expression levels to prevent membrane stress while achieving sufficient display
Optimize codon usage for efficient translation in B. subtilis
Comparison with established display systems:
Evaluate YhcE-based display against established systems using sortase-anchored proteins like YhcR
The YhcR sorting sequence has been successfully used to display recombinant proteins on B. subtilis cell surface, providing a benchmark for comparison
Assess whether YhcE membrane integration provides advantages for certain applications compared to covalent anchoring through sortases
Application potential:
Enzyme immobilization for biocatalysis
Development of whole-cell biosensors
Vaccine antigen presentation
Protein engineering through display-based screening
To investigate YhcE's potential role in antimicrobial resistance:
Antimicrobial susceptibility testing:
Compare minimum inhibitory concentrations (MICs) of various antibiotics between wild-type and yhcE deletion strains
Perform time-kill assays to assess killing kinetics
Evaluate whether yhcE overexpression affects antibiotic susceptibility
Transport assays with antimicrobial compounds:
Measure accumulation of fluorescent antibiotic analogs (e.g., fluorescently labeled daptomycin, vancomycin)
Assess efflux activity using ethidium bromide accumulation/efflux assays
Determine if YhcE-containing transporters can directly transport antibiotics or antibiotic-binding molecules
Resistance development studies:
Perform experimental evolution studies in the presence of antibiotics with wild-type and yhcE mutant strains
Determine if yhcE expression changes in response to antibiotic exposure
Identify potential compensatory mutations that arise in response to yhcE deletion
Membrane composition analysis:
Assess changes in membrane lipid composition in yhcE mutants
Evaluate membrane fluidity and permeability
Determine if YhcE affects the incorporation of specific membrane components that influence antibiotic susceptibility
Designing effective antibodies for YhcE requires specialized approaches:
Epitope selection strategy:
Target extracellular loops between membrane-spanning domains for antibodies intended for surface labeling
Choose cytoplasmic domains for detecting YhcE in lysed cells or Western blots
Avoid hydrophobic transmembrane regions that make poor antigens
Use algorithms to predict antigenic regions with high surface accessibility and hydrophilicity
Antibody production methods:
For polyclonal antibodies: immunize with synthetic peptides corresponding to selected epitopes
For monoclonal antibodies: consider phage display technology with synthetic peptides or purified protein domains
Consider recombinant antibody fragments (Fab, scFv) which may have better access to constrained epitopes
Validation protocols:
Confirm specificity using yhcE deletion strains as negative controls
Perform preabsorption controls with immunizing peptides
Verify detection of YhcE-tagged fusion proteins with known epitope tags
Test antibody performance in multiple applications (Western blot, immunofluorescence, immunoprecipitation)
Application-specific considerations:
For live-cell labeling: use minimal antibody fragments to improve membrane penetration
For co-immunoprecipitation: optimize detergent conditions to maintain protein-protein interactions
For immunofluorescence: consider fixation methods that preserve membrane protein epitopes
Advanced proteomics approaches for YhcE characterization:
Membrane protein-specific sample preparation:
Optimize detergent solubilization conditions to maintain native interactions
Consider alternatives like styrene-maleic acid lipid particles (SMALPs) to extract membrane proteins with their lipid environment
Implement careful fractionation to enrich for membrane proteins
Interactome analysis:
Proximity-dependent labeling techniques (BioID, APEX) to identify proteins in close proximity to YhcE in living cells
Co-immunoprecipitation coupled with mass spectrometry (MS) to identify stable interactors
Chemical crosslinking followed by MS (XL-MS) to map interaction interfaces
Quantitative comparison between wild-type and mutant conditions using SILAC or TMT labeling
Post-translational modification mapping:
Phosphoproteomics to identify regulatory phosphorylation sites
Glycoproteomics to detect potential glycosylation in extracellular domains
Identification of lipid modifications that might affect membrane localization
Use targeted MS approaches (parallel reaction monitoring, PRM) for low-abundance modified peptides
Structural proteomics:
Hydrogen-deuterium exchange MS to probe conformational dynamics
Limited proteolysis coupled with MS to identify protected regions
Native MS to determine oligomeric states and complex composition
Covalent labeling strategies to assess surface accessibility of specific residues
| Technique | Application for YhcE | Advantages | Limitations |
|---|---|---|---|
| BioID | In vivo interactome mapping | Works in native cellular environment | Temporal resolution limited by biotin labeling kinetics |
| XL-MS | Interaction interface mapping | Captures transient interactions | Crosslinking chemistry biases |
| HDX-MS | Conformational dynamics | No size limitation for protein | Lower spatial resolution than crystallography |
| Native MS | Complex composition | Preserves non-covalent interactions | Requires specialized instrumentation |
| PRM | Targeted modification analysis | High sensitivity for specific peptides | Requires prior knowledge of modifications |